Insmed | INSM - Ebitda

Preço das Ações
135.17
Mudança Diária
-8.66 -6.02%
Mensal
-8.86%
Anual
93.96%
Q2 Previsão
132.28




Ebitda Alterar Data
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Cytokinetics USD -277.18M 169.36M 2025-09
DBV Technologies USD -33.48M 5.55M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -314.19M 31.48M 2025-12
Novartis USD 5.84B 235M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09